Scynexis (SCYX) Cost of Revenue (2013 - 2023)

Scynexis (SCYX) posted Cost of Revenue of $14.7 million for Q4 2023, up 3774.41% on a QoQ basis from $379000.0 in Q3 2023, and up 7391.84% year-over-year from $196000.0 in Q4 2022.

Scynexis (SCYX) Cost of Revenue (2013 - 2023) Analysis & Trends

Scynexis' Cost of Revenue history runs 6 years deep, the most recent figure standing at $14.7 million for Q4 2023.

  • Quarterly Cost of Revenue rose 7391.84% year-over-year to $14.7 million in Q4 2023, while the trailing twelve-month figure through Sep 2024 was $14.7 million (up 1190.33% YoY) and the FY2023 annual result came in at $15.6 million, up 2387.9% from the prior year.
  • Cost of Revenue was $14.7 million for Q4 2023 at Scynexis, up from $379000.0 in the prior quarter.
  • Across five years, Cost of Revenue topped out at $14.7 million in Q4 2023 and bottomed at $99000.0 in Q1 2022.
  • A 3-year average of $1.7 million and a median of $178000.0 in 2021 frame the typical range for Cost of Revenue.
  • Annual changes were most pronounced in 2022 — Cost of Revenue increased 17.37% — and 2023, when it surged 7391.84%.
  • Scynexis' Cost of Revenue stood at $167000.0 in 2021, then increased by 17.37% to $196000.0 in 2022, then jumped by 7391.84% to $14.7 million in 2023.
  • Business Quant data shows SCYX's Cost of Revenue at $14.7 million in Q4 2023, $379000.0 in Q3 2023, and $426000.0 in Q2 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn 2.01 Bn
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn 641.00 Mn
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn 2.59 Bn
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn 133.40 Mn
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn 2.36 Bn
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn 13.80 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn 586.00 Mn
10 Scynexis 23.19 Mn -13.57 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2023 14.68 Mn
Dec 31, 2023 14.68 Mn
Sep 30, 2023 379,000.00
Sep 30, 2023 379,000.00
Jun 30, 2023 426,000.00
Jun 30, 2023 426,000.00
Mar 31, 2023 137,000.00
Mar 31, 2023 137,000.00
Dec 31, 2022 196,000.00
Dec 31, 2022 196,000.00
Sep 30, 2022 189,000.00
Sep 30, 2022 189,000.00
Jun 30, 2022 144,000.00
Jun 30, 2022 144,000.00
Mar 31, 2022 99,000.00
Mar 31, 2022 99,000.00
Dec 31, 2021 167,000.00
Dec 31, 2021 167,000.00
Sep 30, 2021 145,000.00
Sep 30, 2021 145,000.00